Related Experiment Video
Updated: May 6, 2026

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
Published on: July 26, 2017
Macrophage-targeted amphiphilic peptide nanocarrier for intracellular MRSA infection therapy
Zaipeng Chen1, Yuling Wu2, Zhiqiang Nie1
1State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, School of Pharmaceutical Sciences, Guizhou Medical University, No. 6 Ankang Avenue, Guian New District, Guiyang, Guizhou 561113, China.
Abstract:
Intracellular bacterial infections pose a significant challenge due to limited cellular internalization, low intracellular antibiotic efficacy, and bacterial sequestration within specific cellular compartments. In this study, we designed an amphiphilic peptide drug delivery system (RFP@TVYV) for sequential targeting of macrophages and intracellular bacteria eradication. By modifying the macrophage-targeting molecule tuftsin, RFP@TVYV facilitates rapid internalization by macrophages. Additionally, the incorporation of Val-Cit fragments, responsive to lysosomal cathepsin B, enables the controlled release of the cell-penetrating peptide YGRKKRRQRRR (TAT) and rifampin (RFP). The inclusion of TAT further enhances subcellular targeting, directing RFP to the bacterial cytoplasm to effectively disrupt intracellular pathogens. Synthesis and characterization studies confirmed that RFP@TVYV self-assembles into stable nanomicelles through hydrogen bonding and hydrophobic interactions. Antibacterial assays demonstrated the nanoplatform's potent activity against Staphylococcus aureus, while flow cytometry (FC) and immunofluorescence (IF) confirmed increased macrophage uptake efficiency and intracellular targeting. Both in vitro and in vivo studies showed that RFP@TVYV significantly reduces intracellular bacterial load more effectively than free RFP, with minimal cytotoxicity. These findings underscore the potential of RFP@TVYV as an advanced drug delivery platform for combating intracellular bacterial infections, particularly those caused by drug-resistant pathogens such as methicillin-resistant Staphylococcus aureus (MRSA).
Insights
This study introduces RFP@TVYV, a novel nanomicelle drug delivery system that enhances macrophage uptake and delivers rifampin (RFP) to eradicate intracellular bacteria like MRSA effectively.
Area of Science:
- Nanotechnology and Drug Delivery
- Infectious Diseases
- Bacteriology
Background:
- Intracellular bacterial infections present challenges due to poor cellular entry and low antibiotic effectiveness within host cells.
- Existing treatments struggle with antibiotic sequestration in cellular compartments, limiting efficacy against intracellular pathogens.
Purpose of the Study:
- To design and evaluate an amphiphilic peptide nanomicelle system (RFP@TVYV) for enhanced macrophage targeting and intracellular bacteria eradication.
- To achieve sequential targeting of macrophages and controlled release of rifampin (RFP) and a cell-penetrating peptide (TAT) for improved antibacterial activity.
Main Methods:
- Synthesis and characterization of RFP@TVYV nanomicelles via hydrogen bonding and hydrophobic interactions.
- Evaluation of macrophage internalization using flow cytometry (FC) and immunofluorescence (IF).
- Assessment of antibacterial activity against Staphylococcus aureus in vitro and in vivo, including cytotoxicity studies.
Main Results:
- RFP@TVYV demonstrated stable nanomicelle formation and significantly enhanced macrophage uptake.
- The system effectively released rifampin (RFP) intracellularly, showing potent activity against Staphylococcus aureus.
- In vitro and in vivo studies confirmed a substantial reduction in intracellular bacterial load with minimal cytotoxicity compared to free RFP.
Conclusions:
- RFP@TVYV is a promising drug delivery platform for overcoming challenges in treating intracellular bacterial infections.
- The nanoplatform shows significant potential for combating drug-resistant pathogens, including methicillin-resistant Staphylococcus aureus (MRSA).
More Related Videos
08:01Synthesis of Monocyte-targeting Peptide Amphiphile Micelles for Imaging of Atherosclerosis
Published on: November 17, 2017
09:36Polyethyleneimine-coated Iron Oxide Nanoparticles as a Vehicle for the Delivery of Small Interfering RNA to Macrophages In Vitro and In Vivo
Published on: February 5, 2019
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Microbial Corrosion
Clinical Significance of Antibiotic Resistance